RCM News and Press, R1 RCM Inc. From 03/17/23

2023-03-17 15:00:38 ET The following slide deck was published by R1 RCM Inc. in conjunction with this event. For further details see: R1 RCM (RCM) presents at Barclays Global Healthcare Conference - Slideshow

2023-03-10 08:47:27 ET The following slide deck was published by R1 RCM Inc. in conjunction with this event. For further details see: R1 RCM (RCM) Presents at the 43rd Annual Cowen Healthcare Conference - Slideshow

Summary The Cloudmed integration appears to be already paying dividends for R1 RCM as a growth accelerator. Projections are for 48% YoY adj. EBITDA growth in FY23. The company looks undervalued at 12.75x forward EBITDA. I reiterate a buy rating, revising my price target higher t...

MURRAY, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today released its 2022 Environmental, Social, and Governance (ESG) repor...

Shares of the healthcare services company R1 RCM (NASDAQ: RCM) were up by a healthy 10.1% on higher-than-normal volume, as of 11:35 a.m. ET Thursday morning. The company's shares are marching higher in response to a better-than-expected 2022 fourth-quarter earnings report released ahe...

R1 RCM, Inc. (RCM) Q4 2022 Earnings Conference Call February 16, 2023, 8:00 am ET Company Participants Atif Rahim - Head, IR Lee Rivas - CEO Jennifer Williams - EVP & CFO Conference Call Participants Charles Rhyee - Cowen Michael Cherney - Bank of A...

The following slide deck was published by R1 RCM Inc. in conjunction with their 2022 Q4 earnings call. For further details see: R1 RCM Inc. 2022 Q4 - Results - Earnings Call Presentation

R1 RCM press release ( NASDAQ: RCM ): Q4 GAAP EPS of -$0.09 misses by $0.04 . Revenue of $532.8M (+33.6% Y/Y) beats by $13.52M . Adjusted EBITDA of $125.0 million, up $29.9 million or 31.4% compared to the same period last year For 2023, R1 expects to generate: ...

MURRAY, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2022. ...

R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q4 earnings results on Thursday, February 16th, before market open. The consensus EPS Estimate is $0.04 (-63.6% Y/Y) and the consensus Revenue Estimate is $519.28M (+30.2% Y/Y). Over the last 1 year, RCM has beaten EPS estimate...